| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |